$0.8789
At close: May 28 EDT
$0.8681
-0.01-1.23%
Pre-Market: 8:27 AM EDT
Comments
Loading...
Xilio Therapeutics (XLO) Forecast
NewsEarningsXilio Therapeutics (XLO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Xilio Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:XLO | Benzinga
Explore Xilio Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for XLO.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Xilio Therapeutics (XLO) stock?
You can purchase shares of Xilio Therapeutics (NASDAQ:XLO) through any online brokerage.
Who are Xilio Therapeutics (XLO) competitors?
Other companies in Xilio Therapeutics’s space includes: Adverum Biotechnologies (NASDAQ:ADVM), Gain Therapeutics (NASDAQ:GANX), bluebird bio (NASDAQ:BLUE), Connect Biopharma Hldgs (NASDAQ:CNTB) and PepGen (NASDAQ:PEPG).
What is the forecast, or price target, for Xilio Therapeutics (XLO) stock?
Xilio Therapeutics has a consensus price target of $7.00.
What is the current price for Xilio Therapeutics (XLO)?
The stock price for Xilio Therapeutics (NASDAQ: XLO) is $0.8681 last updated May 28, 2025 at 8:27 AM EDT.
Does Xilio Therapeutics (XLO) pay a dividend?
There are no upcoming dividends for Xilio Therapeutics.
When is Xilio Therapeutics (NASDAQ:XLO) reporting earnings?
Xilio Therapeutics’s Q2 earnings are confirmed for Thursday, August 7, 2025.
Is Xilio Therapeutics (XLO) going to split?
There is no upcoming split for Xilio Therapeutics.
What sector and industry does Xilio Therapeutics (XLO) operate in?
Xilio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
